Ivrea, Italy

Michele Mondini

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of Piemonte Orientale. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michele Mondini. Retrieved from https://idiyas.com/inventor/michele-mondini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michele Mondini: Innovator in Therapeutic Agents

Introduction

Michele Mondini is a notable inventor based in Ivrea, Italy. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of autoimmune and inflammatory disorders. His innovative work has the potential to impact many lives.

Latest Patents

Michele Mondini holds a patent titled "Extracellular IFI16 as therapeutic agents." This invention focuses on the inhibition of the circulating extracellular form of the interferon-inducible protein 16 (extracellular IFI16) for treating various diseases, especially autoimmune and inflammatory disorders or infective disorders. He has 1 patent to his name.

Career Highlights

Michele Mondini is affiliated with the University of Piemonte Orientale, where he continues to advance his research and innovation in the medical field. His work is characterized by a commitment to developing new therapeutic strategies that can improve patient outcomes.

Collaborations

Michele collaborates with esteemed colleagues such as Silvia Costa and Marisa Gariglio. Their combined expertise enhances the research efforts and contributes to the advancement of therapeutic solutions.

Conclusion

Michele Mondini's innovative work in the field of therapeutic agents showcases his dedication to addressing critical health issues. His contributions are paving the way for new treatments that could benefit many individuals suffering from autoimmune and inflammatory disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…